Welcome and thanks for reading! In this review, I will
gather together important and interesting news and events over the last week
related to my portfolio holdings. In my week review, I put also together some
interesting articles from other websites that caught my attention during the
past week.
Sunday, June 26, 2016
Friday, June 24, 2016
Recent Buy - Gilead Sciences Inc. (GILD)
Today on 24th June I Bought 20 shares of Gilead Sciences Inc. at $ 79.89 per share plus commission.
Gilead Sciences, Inc., a research-based biopharmaceutical
company, discovers, develops, and commercializes medicines in areas of unmet
medical needs in North America, South America, Europe, and the Asia-Pacific.
The companys products include Genvoya, Stribild, Complera/Eviplera, Atripla,
Truvada, Viread, Emtriva, Tybost, and Vitekta for the treatment of human
immunodeficiency virus (HIV) infection in adults; and Harvoni, Sovaldi, Viread,
and Hepsera products for the treatment of liver diseases. It also offers
Zydelig, a PI3K delta inhibitor, in combination with rituximab, for the
treatment of certain blood cancers; Letairis, an endothelin receptor antagonist
for the treatment of pulmonary arterial hypertension; Ranexa, a tablet used for
the treatment of chronic angina; Lexiscan/Rapiscan injection for use as a
pharmacologic stress agent in radionuclide myocardial perfusion imaging;
Cayston, an inhaled antibiotic for the treatment of respiratory systems in
cystic fibrosis patients; and Tamiflu, an oral antiviral capsule for the
treatment and prevention of influenza A and B. In addition, the company
provides other products, such as AmBisome, an antifungal agent to treat serious
invasive fungal infections; and Macugen, an anti-angiogenic oligonucleotide to
treat neovascular age-related macular degeneration. Further, it has product
candidates in various stages of development for the treatment of HIV/AIDS and
liver diseases, such as hepatitis B virus and hepatitis C virus;
inflammation/oncology; serious cardiovascular; and respiratory conditions, as
well as diabetic nephropathy and ebola. The company markets its products
through its commercial teams and/or in conjunction with third-party
distributors and corporate partners. Gilead Sciences, Inc. has collaboration agreements
with Bristol-Myers Squibb Company, Janssen R&D Ireland, Japan Tobacco Inc.,
and Galapagos NV. The company was founded in 1987 and is headquartered in
Foster City, California.
Sunday, June 19, 2016
Week in Review 24/16
Welcome and thanks for reading! In this review, I will
gather together important and interesting news and events over the last week
related to my portfolio holdings. In my week review, I put also together some
interesting articles from other websites that caught my attention during the
past week.
Friday, June 17, 2016
Recent Buy - Magna International Inc. (MGA)
16th June I Bought 50 shares of Magna International Inc. at $ 38.33 per share plus commission.
Magna International Inc. develops, manufactures,
engineers, supplies, and sells automotive products. It operates through North
America, Europe, Asia, and Rest of World segments. The company offers body and
chassis systems, and related engineering services; seating systems, including
complete seating systems, seat structures and mechanisms, and foam and trim
products; and powertrain systems, such as transmissions, driveline systems,
fluid pressure and controls, metal forming solutions, and engineering services.
It also provides vision systems comprising interior and exterior mirrors,
actuators, door handle illumination products, headlamps and tail lamps, and
small lighting products; and closure systems comprising door modules, power
closure systems, engineered glass products, window systems, running boards and
roof racks, latching systems, lighting systems, sealing systems, electronic
features, handle assemblies, composite components, and hinges and rods. In
addition, the company provides electronic systems, including driver assistance
systems, secure connectivity products, head-up displays, and electronic
controllers; exterior systems, such as fascia and trim products, front end
modules, liftgate and exterior modules, active aerodynamics, and lightweight
composites; and roof systems, including sliding folding and modular roofs,
retractable hard tops, and soft tops. Further, it offers vehicle engineering
and contract vehicle assembly services; fuel systems; engineering support
services; and tooling and other products. The company was founded in 1957 and
is headquartered in Aurora, Canada.
Sunday, June 12, 2016
Week in Review 23/16
Welcome and thanks for reading! In this review, I will
gather together important and interesting news and events over the last week
related to my portfolio holdings. In my week review, I put also together some
interesting articles from other websites that caught my attention during the
past week.
Thursday, June 9, 2016
Dividend Increase – Target Corporation (TGT)
Yesterday the Board of Directors of Target Corporation announced a
quarterly dividend increase of from $0.56
to $0.60 per share that’s payable September 10, 2016 to holders of record August17 , 2016. This represents a 7.14% increase to regular quarterly
dividends. With current price $68.35 (yesterdays open), this raise
brings
their
dividend yield to 3.51%.
Since I own 100 shares, this will increase my portfolio's projected annual net dividend income by $11.92.
That increase rises my YOC to 4.18%.
Click here
to see my portfolio holdings.
Wednesday, June 8, 2016
Dividend Income - May 2016
Again, one month passed and it is time to report my
dividend income. In May 2016 my portfolio dividend income was as follows:
Annual dividend received from:
Tele2 B (TEL2-B) - €115.24 ($128.40)
Annual dividend received from:
Tele2 B (TEL2-B) - €115.24 ($128.40)
Quarterly dividends received from:
AT&T Inc. (T) - €130.45 ($148.80)
Toronto-Dominion Bank (TD.TO) - €58.28 ($64.95)
Avance Gas Holding Ltd. (AVANCE) - €104.04 ($120.00)
Toronto-Dominion Bank (TD.TO) - €58.28 ($64.95)
Avance Gas Holding Ltd. (AVANCE) - €104.04 ($120.00)
Kinder Morgan Inc. (KMI) - €22.09 ($25.01)
ONEOK Inc. (OKE) - €27.19 ($30.75)
ONEOK Inc. (OKE) - €27.19 ($30.75)
Omega Healthcare Investors (OHI) - €50.35 ($57.00)
Eaton Corporation (ETN) - €15.23 ($17.10)
Eaton Corporation (ETN) - €15.23 ($17.10)
HCP Inc. (HCP) - €51.61 ($57.50)
Royal Bank of Canada (RY.TO) - €66.93 ($76.80)
Alerian MLP ETF (AMLP) - €107.15 ($120.00)
TAL International Group Inc. (TAL) - €40.49 ($45.00)
TAL International Group Inc. (TAL) - €40.49 ($45.00)
Sunday, June 5, 2016
Week in Review 22/16
Welcome and thanks for reading! In this review, I will
gather together important and interesting news and events over the last week
related to my portfolio holdings. In my week review, I put also together some
interesting articles from other websites that caught my attention during the
past week.
Subscribe to:
Posts (Atom)